MENU
+Compare
ELV
Stock ticker: NYSE
AS OF
Dec 24, 02:00 PM (EDT)
Price
$373.12
Change
+$2.23 (+0.60%)
Capitalization
120.06B

ELV stock forecast, quote, news & analysis

ELV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for ELV with price predictions
Dec 23, 2024

Momentum Indicator for ELV turns negative, indicating new downward trend

ELV saw its Momentum Indicator move below the 0 level on December 05, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In of the 93 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ELV turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ELV entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ELV's RSI Indicator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELV advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

ELV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.054) is normal, around the industry mean (3.063). P/E Ratio (20.460) is within average values for comparable stocks, (17.509). Projected Growth (PEG Ratio) (0.863) is also within normal values, averaging (1.089). Dividend Yield (0.012) settles around the average of (0.020) among similar stocks. P/S Ratio (0.715) is also within normal values, averaging (0.684).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ELV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

ELV paid dividends on December 20, 2024

Elevance Health ELV Stock Dividends
А dividend of $1.63 per share was paid with a record date of December 20, 2024, and an ex-dividend date of December 05, 2024. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), CVS HEALTH Corp (NYSE:CVS), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 68.32B. The market cap for tickers in the group ranges from 3.42M to 451.47B. UNH holds the highest valuation in this group at 451.47B. The lowest valued company is HRAA at 3.42M.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was 11%. For the same Industry, the average monthly price growth was 15%, and the average quarterly price growth was 15%. IHGP experienced the highest price growth at 50%, while NEUE experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was -35%. For the same stocks of the Industry, the average monthly volume growth was 10% and the average quarterly volume growth was 66%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 71
Price Growth Rating: 59
SMR Rating: 83
Profit Risk Rating: 80
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
ELV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a provider of life, hospital and medical insurance plans

Industry ManagedHealthCare

Profile
Fundamentals
Details
Industry
Managed Health Care
Address
220 Virginia Avenue
Phone
+1 833 401-1577
Employees
104900
Web
https://www.elevancehealth.com